MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
出版年份 2012 全文链接
标题
MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
作者
关键词
-
出版物
CARCINOGENESIS
Volume 34, Issue 3, Pages 530-538
出版商
Oxford University Press (OUP)
发表日期
2012-11-28
DOI
10.1093/carcin/bgs371
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA Regulation of Cancer Stem Cells
- (2011) C. Liu et al. CANCER RESEARCH
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
- (2011) A. Bronisz et al. NATURE CELL BIOLOGY
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- MicroRNAs, cancer and cancer stem cells
- (2010) Amy L. Zimmerman et al. CANCER LETTERS
- Revisiting the concept of cancer stem cells in prostate cancer
- (2010) Z A Wang et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
- (2010) Dejuan Kong et al. PLoS One
- LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
- (2009) Y. Li et al. CANCER RESEARCH
- Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
- (2009) D. J. Mulholland et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
- (2009) Isabelle Bisson et al. CELL RESEARCH
- MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20
- (2009) Xiao-Ping Ren et al. CIRCULATION
- miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation
- (2009) Dale G. Schaar et al. EXPERIMENTAL HEMATOLOGY
- PTEN, Stem Cells, and Cancer Stem Cells
- (2009) Reginald Hill et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs in Cancer: Small Molecules With a Huge Impact
- (2009) Marilena V. Iorio et al. JOURNAL OF CLINICAL ONCOLOGY
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- A luminal epithelial stem cell that is a cell of origin for prostate cancer
- (2009) Xi Wang et al. NATURE
- MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
- (2009) K-H Lee et al. ONCOGENE
- Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer
- (2009) Kwang-Hyuck Lee et al. PANCREATOLOGY
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
- (2008) T. Schepeler et al. CANCER RESEARCH
- SOX9 Is Expressed in Human Fetal Prostate Epithelium and Enhances Prostate Cancer Invasion
- (2008) H. Wang et al. CANCER RESEARCH
- K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse
- (2008) H. B. Pearson et al. CANCER RESEARCH
- A microRNA component of the hypoxic response
- (2008) R Kulshreshtha et al. CELL DEATH AND DIFFERENTIATION
- Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
- (2008) Wenyan Lu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
- (2008) Ilaria Malanchi et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started